🫁Exciting insights from Charles Swanton at #BTOG24 on the link between air pollution and lung cancer initiation, shedding light on tumor formation mechanisms in never smokers:

➡️ow.ly/vlG050Roix9⬅️

Cancer Research UK BTOG #LCSM #NSCLC

Missing #BTOG24 ? Don’t worry, we’ve got plenty of key highlights and coverage over at VJOncology.com!

Click here ➡️vjoncology.com/event/btog-2024

BTOG #LungCancer #LCSM #NSCLC #SCLC #Mesothelioma

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Michael Morris Mike Morris👉Regular conventional imaging is must in pts with mCSPC #ProstateCancer 👉Arches trial data showed imaging progression (minus PSA rise) in many, and lineage plasticity makes PSA/PSMA unreliable. OncoAlert silke gillessen

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 outstanding talk by Nick James on triplet vs doublet therapy in mCSPC #ProstateCancer 👉gives shoutout to network meta-analysis by SOUMYAJIT ROY 👉value of triplet unclear in all pts, pts QOL should be considered OncoAlert silke gillessen

Just out #APCCC2024 Advanced Prostate Cancer Consensus Conference
Tweet OncoAlert Faculty Neeraj Agarwal, MD, FASCO 🇺🇸
talk by prof. Barbara Jereczek-Fossa on “When salvage radiation (RT) can be delayed in #ProstateCancer with PSA recurrence?”👉given potentially curative RT, need to identify pts w very low risk BCR before delaying RT

#APCCC24 Advanced Prostate Cancer Consensus Conference Insightful talk by Dr. prof. Barbara Jereczek-Fossa on “When salvage radiation (RT) can be delayed in #ProstateCancer with PSA recurrence?”👉given potentially curative RT, need to identify pts with very low risk BCR before delaying RT OncoAlert PCF Science UroToday.com

Great opening talk on the patient perspective from David Matheson - need to look at wellness as well as illness #APCCC24

Evolving strategies suggest that precision in radiation therapy could be a key factor in enhancing treatment efficacy while managing side effects. Neha Vapiwala Exceptional presentation.
#Apccc24 Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin OncoAlert Thomas Zilli Daniel Castellano Piet Ost…

#APCCC24 Advanced Prostate Cancer Consensus Conference outstanding talk by Daniel E Spratt on personalization of Rx in localized #ProstateCancer 👉Role of AI based biomarkers and genomic classifiers for de-
and escalation of Rx 👇 OncoAlert UroToday.com silke gillessen Neha Vapiwala aurelius omlin

Have you got #ESMOBreast24 in your diary yet?

Less than a month to go until we get to see much awaited updates in #breastcancer !!

🗓️15th - 17th May 🗓️

@‌myESMO #bcsm

🎥Natasha Leighl, MD, from University of Toronto shares insights from the CHRYSALIS trial at #AACR24 , revealing promising responses to amivantamab in pts w/ #NSCLC , with notable exceptions in KRAS or HER2 mutations:

➡️ow.ly/fIeR50RmqZp⬅️

#LungCancer #CTSM #ImmunoOnc

April is #BowelCancer Awareness Month 📣

Did you know we have a #GICancer Channel, dedicated to bringing you the latest news & updates? 🎥 🗞️ 🎧

Explore the channel 👉vjoncology.com/subject/gastro…

#Oncology #BowelCancer AwarenessMonth #Oncology news #CRCsm

🎥Tatsuhiro Shibata, MD, PhD, of UTokyo | 東京大学 sheds light on promising biomolecular targets for gastric and gastroesophageal cancers at #AACR24 . From EGFR2 to ICIs, his insights offer hope for future treatments in this challenging area:

➡️ow.ly/MtxE50RlxP2

#Oncology

We are keen to evaluate this very promising approach in patients with advanced ovarian cancer in collaboration with Rebecca Porter Dana-Farber

It's day 2 of #iwCART 24 and the first session of the day will highlight scientific challenges and new approaches!

Explore CD83 as a target for hematologic malignancies with Marco Davila

#MultipleMyeloma #MMsm #iwCART 24 VJHemOnc #iwCART #CART #CellularTherapies

Out on JAMA 🚨
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

In patients with early-stage Triple Negative #BreastCancer who did not undergo adjuvant or neoadjuvant chemotherapy🧪

➡️breast cancer tissue with a higher abundance of TIL levels was…

Functional #QOL among newly diagnosed early-onset #colorectalcancer by Dr. Oswald et al Moffitt Cancer Center multidisciplinary collaboration as part of the #ColoCare Study

Sheetal Hardikar Victoria Damerell, PhD Nicole Loroña, PhD
Neli Ulrich, PhD

link.springer.com/article/10.100…

OncoAlert Cancer at Cedars-Sinai

Joel Randolph Hecht discusses T-cell therapy for GI tumors at #iwCART 24 . Join us as we explore innovative approaches to gastrointestinal cancer treatment!

#iwCART 24 VJ Oncology #iwCART #CART #CellularTherapies

Benjamin Schlechter introduces autologous TAC T-cells targeting solid tumors, HER2, and Claudin18.2 at #iwCART 24 . Promising advancements in personalized therapy!

#iwCART 24 VJ Oncology #iwCART #CART #CellularTherapies

🚨 Diane M. Simeone, MD shares CAR-T advances in #PancreaticCancer at #iwCART 24 . Stay informed about the latest breakthroughs in #GICancer therapy!

#iwCART 24 VJ Oncology #iwCART #CART #CellularTherapies #GIsm